Company Overview of Q-Med AB
Q-Med AB, a medical device company, engages in the development, manufacture, marketing, and sale of medical implants for esthetic and medical use. The company’s products are based on its patented technology, NASHA, for the production of stabilized non-animal hyaluronic acid. Its products include Restylane products for filling out wrinkles and contouring lips; Macrolane VRF for body shaping; Deflux, which is used in the treatment of vesicoureteral reflux in children; Durolane for the treatment of osteoarthritis of the knee and hip joints; and Solesta for the treatment of fecal incontinence. Q-Med sells its products through subsidiaries or distributors worldwide. The company was founded in 198...
Uppsala, 752 28
Founded in 1987
Key Executives for Q-Med AB
Interim Chief Executive Officer and General Counsel
Founder, Executive Chairman and Member of Election Committee
Chief Financial Officer and Vice President
Director of Investor Relations and Corporate Communications
Head of Corporate Communications
Compensation as of Fiscal Year 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries